NO875442L - Nye oligosaccharider, immunogener og vaksiner og fremgangsmaater ved fremstilling derav. - Google Patents

Nye oligosaccharider, immunogener og vaksiner og fremgangsmaater ved fremstilling derav.

Info

Publication number
NO875442L
NO875442L NO875442A NO875442A NO875442L NO 875442 L NO875442 L NO 875442L NO 875442 A NO875442 A NO 875442A NO 875442 A NO875442 A NO 875442A NO 875442 L NO875442 L NO 875442L
Authority
NO
Norway
Prior art keywords
vaccines
immunogenes
procedures
producing
oligosaccharides
Prior art date
Application number
NO875442A
Other languages
English (en)
Other versions
NO169775B (no
NO169775C (no
NO875442D0 (no
Inventor
Eduard Coen Beuvery
Adolf Evenberg
Jan Theunis Poolman
Jacobus Hubertus Van Boom
Peter Hoogerhout
Constant Adriaan Anton Boeckel
Original Assignee
Rivm Of Bilthoven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rivm Of Bilthoven filed Critical Rivm Of Bilthoven
Publication of NO875442D0 publication Critical patent/NO875442D0/no
Publication of NO875442L publication Critical patent/NO875442L/no
Publication of NO169775B publication Critical patent/NO169775B/no
Publication of NO169775C publication Critical patent/NO169775C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO875442A 1986-12-31 1987-12-28 Analogifremgangsmaate for fremstilling av nye oligosaccharider NO169775C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8603325 1986-12-31

Publications (4)

Publication Number Publication Date
NO875442D0 NO875442D0 (no) 1987-12-28
NO875442L true NO875442L (no) 1988-07-01
NO169775B NO169775B (no) 1992-04-27
NO169775C NO169775C (no) 1992-08-05

Family

ID=19849078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875442A NO169775C (no) 1986-12-31 1987-12-28 Analogifremgangsmaate for fremstilling av nye oligosaccharider

Country Status (15)

Country Link
US (1) US5034519A (no)
EP (1) EP0276516B1 (no)
JP (1) JPS63190896A (no)
KR (1) KR880007557A (no)
AT (1) ATE87003T1 (no)
AU (1) AU603405B2 (no)
CA (1) CA1335405C (no)
DE (1) DE3784907T2 (no)
DK (1) DK694687A (no)
ES (1) ES2054657T3 (no)
FI (1) FI89172C (no)
IE (1) IE59734B1 (no)
NO (1) NO169775C (no)
NZ (1) NZ223009A (no)
PT (1) PT86484B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
DE68915046T2 (de) * 1988-04-19 1994-12-08 American Cyanamid Co Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
EP0378929A3 (en) * 1988-12-23 1990-08-01 Connaught Laboratories Limited Membrane proteins and peptides of haemophilus influenzae type b
GB8924473D0 (en) * 1989-10-31 1989-12-20 Connaught Lab Outer membrane protein p1 and peptides of haemophilus influenzae b
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
DK0565590T3 (da) * 1990-12-21 1999-09-27 Antex Biolog Inc Adhesin-oligosaccharid-konjugatvaccine mod Haemophilus influenzae
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
DE69126522T2 (de) * 1991-05-20 1997-11-06 Kao Corp Neue Phosphobetain und die enthaltende Detergenz und Cosmetica
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
DE122007000099I1 (de) * 1992-06-25 2008-03-27 Papillomavirus vakzine
US7148031B2 (en) 1994-07-26 2006-12-12 The Mitre Corporation Sequestering of glycoprotein molecules and oligosaccharide moieties in lipo-glycoprotein membranes and micelles
US5782396A (en) 1995-08-28 1998-07-21 United States Surgical Corporation Surgical stapler
US6032849A (en) * 1995-08-28 2000-03-07 United States Surgical Surgical stapler
US5762256A (en) * 1995-08-28 1998-06-09 United States Surgical Corporation Surgical stapler
SE9601158D0 (sv) * 1996-03-26 1996-03-26 Stefan Svenson Method of producing immunogenic products and vaccines
ES2166097T5 (es) * 1996-08-27 2007-03-16 Novartis Vaccines And Diagnostics, Inc. Glicoconjugados de neisseria meningitidis de serogrupo b y procedimientos para usarlos.
US6267961B1 (en) * 1996-11-22 2001-07-31 Baxter International Inc. Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation
CU22904A1 (es) * 1999-08-30 2004-01-23 Univ De Ottawa Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
US8785134B2 (en) 2008-11-10 2014-07-22 The Mitre Corporation Glycoprotein vesicles and their methods of use
JP6784841B2 (ja) 2016-07-28 2020-11-11 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー ヘモフィルス属インフルエンザ菌ｂ型に対するワクチンとしての安定した加水分解耐性合成ポリリボシルリビトールホスフェート誘導体
CN108776223B (zh) * 2018-04-19 2021-04-06 广州质量监督检测研究院 紫外吸收剂uv-326检测试剂盒及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine

Also Published As

Publication number Publication date
ES2054657T3 (es) 1994-08-16
DE3784907D1 (de) 1993-04-22
EP0276516A3 (en) 1988-08-17
NO169775B (no) 1992-04-27
AU603405B2 (en) 1990-11-15
DE3784907T2 (de) 1993-06-24
US5034519A (en) 1991-07-23
DK694687D0 (da) 1987-12-30
KR880007557A (ko) 1988-08-27
AU8314587A (en) 1988-07-07
CA1335405C (en) 1995-04-25
ATE87003T1 (de) 1993-04-15
IE59734B1 (en) 1994-03-23
JPS63190896A (ja) 1988-08-08
FI875727A0 (fi) 1987-12-28
PT86484A (en) 1988-01-01
FI875727L (fi) 1988-07-01
EP0276516B1 (en) 1993-03-17
NO169775C (no) 1992-08-05
FI89172B (fi) 1993-05-14
NO875442D0 (no) 1987-12-28
NZ223009A (en) 1990-06-26
DK694687A (da) 1988-07-01
PT86484B (pt) 1990-11-20
IE873510L (en) 1988-06-30
EP0276516A2 (en) 1988-08-03
FI89172C (fi) 1993-08-25

Similar Documents

Publication Publication Date Title
NO875442D0 (no) Nye oligosaccharider, immunogener og vaksiner og fremgangsmaater ved fremstilling derav.
PT94543A (pt) Processo para a preparacao de trp-phe-e fenetilaminas alfa-substituidas por ciclo-alquilo e poli-ciclo-alquilo n-substituidos
NO174630C (no) Fremgangsmåte ved fremstilling av en vaksine mot streptokokkinfeksjoner
ES520259A0 (es) Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
NO982849D0 (no) Separasjon av middels h°ytkokende fraksjoner fra en blanding av lav, middelse og h°ytkokende fraksjoner
PT70610A (fr) Procede de preparation de proteoglycanes bacteriens destines a etre incorpores avec un vaccin et vaccin qui les contient
DK22389A (da) Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma
DK656687A (da) Bakterielle antigener, antistoffer, vacciner og fremgangsmaade til fremstilling deraf
NO864147L (no) Fremgangsmaate for fremstilling av alginater(polyuronider) med endrede fysikalske egenskaper.
ZA874625B (en) Stabilizers for live vaccines,process for their preparation and vaccines containing them
DK0515415T3 (da) Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf
GR1001125B (el) Μεθοδος δια την εις βιομηχανικη κλιμακα παραγωγην της βμυ 21502.
HU906509D0 (en) Process for producing vaccine against virus of infecting bronchitis
PT88420A (pt) Process for the preparation of pharmaceutical compositions containing 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil and a method for treating hepatitis virus infections by using said compositions
GB2007244A (en) Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP
DE3364803D1 (en) Method of preparing an immunogen of pasteurella multocida
SE7710548L (sv) Forfarande for framstellning av keramiska material
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
PT86745A (pt) Process for preparing oxime ethers of 2,6-dioxabicyclo ]3.3.o" octanones
JPS6463528A (en) Production of azulene derivative
Santos et al. Development of Vitreous Silica by the Sol--Gel Method
RU93005000A (ru) Композиция вакцин, способ ее получения, способ исключения иммунной реакции
IT8620526A1 (it) Processo per la preparazione del 3,4-dimetossifenilacetone
FR2397458A1 (fr) Procede de preparation de vaccin vivant contre les oreillons
IT8622272A0 (it) Metodo per l'identificazione immediata da colture di salmonella e preparazione del reattivo impiegato.